spacer
spacer

PDBsum entry 2cb5

Go to PDB code: 
protein Protein-protein interface(s) links
Hydrolase PDB id
2cb5

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
453 a.a. *
Waters ×564
* Residue conservation analysis
PDB id:
2cb5
Name: Hydrolase
Title: Human bleomycin hydrolase, c73s/dele455 mutant
Structure: Protein (bleomycin hydrolase). Chain: a, b. Engineered: yes. Mutation: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Cellular_location: cytoplasm. Expressed in: escherichia coli. Expression_system_taxid: 562.
Biol. unit: Hexamer (from PQS)
Resolution:
1.85Å     R-factor:   0.182     R-free:   0.210
Authors: P.A.O'Farrell,F.Gonzalez,W.Zheng,S.A.Johnston,L.Joshua-Tor
Key ref:
P.A.O'Farrell et al. (1999). Crystal structure of human bleomycin hydrolase, a self-compartmentalizing cysteine protease. Structure, 7, 619-627. PubMed id: 10404591 DOI: 10.1016/S0969-2126(99)80083-5
Date:
02-Mar-99     Release date:   06-Mar-00    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
Q13867  (BLMH_HUMAN) -  Bleomycin hydrolase from Homo sapiens
Seq:
Struc:
455 a.a.
453 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 3 residue positions (black crosses)

 Enzyme reactions 
   Enzyme class: E.C.3.4.22.40  - bleomycin hydrolase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: Inactivates bleomycin B2 (a cytotoxic glycometallopeptide) by hydrolysis of a carboxyamide bond of b-aminoalanine, but also shows general aminopeptidase activity. The specificity varies somewhat with source, but amino acid arylamides of Met, Leu and Ala are preferred.

 

 
DOI no: 10.1016/S0969-2126(99)80083-5 Structure 7:619-627 (1999)
PubMed id: 10404591  
 
 
Crystal structure of human bleomycin hydrolase, a self-compartmentalizing cysteine protease.
P.A.O'Farrell, F.Gonzalez, W.Zheng, S.A.Johnston, L.Joshua-Tor.
 
  ABSTRACT  
 
BACKGROUND: Bleomycin hydrolase (BH) is a cysteine protease that is found in all tissues in mammals as well as in many other eukaryotes and prokaryotes. Although its conserved cellular function is as yet unknown, human bleomycin hydrolase (hBH) has clinical significance in that it is thought to be the major cause of tumor cell resistance to bleomycin chemotherapy. In addition, it has been reported that an allelic variant of hBH is genetically linked to Alzheimer's disease. RESULTS: We have determined the crystal structures of wild-type hBH and of a mutant form of the enzyme. The overall structure is very similar to that of the previously determined yeast homolog, however, there is a striking difference in the charge distribution. The central channel, which has a strong positive electrostatic potential in the yeast protein, is slightly negative in hBH. We have determined that hBH does not have the DNA-binding activity of the yeast protein and that the enzyme is localized to the cytoplasm. CONCLUSIONS: The difference in charge distribution between the yeast and human BH enzymes is most likely responsible for the difference in DNA-binding activity. Nevertheless, the C-terminal autoprocessing activity and the role of the C terminus as a determinant for peptidase activity are conserved between the yeast and human forms. The structure of hBH suggests that the putative Alzheimer's disease linked variation does not directly alter the intrinsic peptidase activity. Rather, the position of the mutation suggests that it could affect interactions with another protein, which may modulate peptidase activity through repositioning of the C terminus.
 
  Selected figure(s)  
 
Figure 3.
Figure 3. The C terminus of hBH. Residues 447–454 of the wild-type protein, as well as the catalytic Cys73, are shown as bonds colored according to atom type. The corresponding residues of the Cys73→Ser/ΔGlu455 mutant protein are shown in cyan. The sidechains of the catalytic residues His372 and Asp396 are shown with yellow bonds, as is the sidechain of Gln67, which stabilizes the oxyanion intermediate during catalysis. Hydrogen-bond interactions of the mutant protein – between the C-terminal alanine and the sidechain of Gln67 and the amide nitrogen atoms of Ser73 and Trp74, and between Ser73 and the backbone amide of residue 373 – are shown as dotted white lines. Arrows indicate the Cα atoms of labeled residues. Gly451 is the elbow at which the C-terminal arm rotates and extends.
 
  The above figure is reprinted by permission from Cell Press: Structure (1999, 7, 619-627) copyright 1999.  
  Figure was selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
20198498 M.A.Smach, B.Charfeddine, T.Lammouchi, L.B.Othman, A.Letaief, S.Nafati, H.Dridi, S.Bennamou, and K.Limem (2010).
Analysis of association between bleomycin hydrolase and apolipoprotein E polymorphism in Alzheimer's disease.
  Neurol Sci, 31, 687-691.  
20615447 P.Goettig, V.Magdolen, and H.Brandstetter (2010).
Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs).
  Biochimie, 92, 1546-1567.  
18817889 C.R.Berkers, A.de Jong, H.Ovaa, and B.Rodenko (2009).
Transpeptidation and reverse proteolysis and their consequences for immunity.
  Int J Biochem Cell Biol, 41, 66-71.  
17937605 H.Jakubowski (2007).
The molecular basis of homocysteine thiolactone-mediated vascular disease.
  Clin Chem Lab Med, 45, 1704-1716.  
16769724 J.Zimny, M.Sikora, A.Guranowski, and H.Jakubowski (2006).
Protective mechanisms against homocysteine toxicity: the role of bleomycin hydrolase.
  J Biol Chem, 281, 22485-22492.  
12555812 H.Wang, and D.Ramotar (2002).
Cellular resistance to bleomycin in Saccharomyces cerevisiae is not affected by changes in bleomycin hydrolase levels.
  Biochem Cell Biol, 80, 789-796.  
16233174 M.Sugiyama, and T.Kumagai (2002).
Molecular and structural biology of bleomycin and its resistance determinants.
  J Biosci Bioeng, 93, 105-116.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time.

 

spacer

spacer